Elicio Therapeutics, Inc.
ELTX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001601485
No open-market purchases or sales by Elicio Therapeutics, Inc. insiders were filed in the last 90 days; 48 institutions reported holding it in 13F filings for Q2 2026, worth $15.3M in total; no superinvestor holds it.
13F holders, Q3 2022
Institutional positions in Elicio Therapeutics, Inc. as of Sep 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 38
- −5 vs. Q2 2022
- Shares held
- 5.12M
- −57.7K (−1.1%) vs. Q2 2022
- Total value
- $4.71M
- −$1.19M (−20.2%) vs. Q2 2022
- New holders
- 3
- 9 more added
- Sold out
- 8
- 16 more reduced
Compare with Q2 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ELTX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 48 | $15.3M |
| Q1 2026 | 47 | $28.2M |
| Q4 2025 | 37 | $16.6M |
| Q3 2025 | 28 | $20.9M |
| Q2 2025 | 21 | $11.2M |
| Q1 2025 | 24 | $9.80M |
| Q4 2024 | 17 | $2.25M |
| Q3 2024 | 18 | $2.48M |
| Q2 2024 | 20 | $2.68M |
| Q1 2024 | 18 | $3.08M |
| Q4 2023 | 18 | $2.78M |
| Q3 2023 | 18 | $2.80M |
| Q2 2023 | 15 | $2.71M |
| Q1 2023 | 28 | $2.56M |
| Q4 2022 | 30 | $3.98M |
| Q3 2022 | 38 | $4.71M |
| Q2 2022 | 43 | $5.90M |
| Q1 2022 | 47 | $13.8M |
| Q4 2021 | 53 | $20.3M |
| Q3 2021 | 47 | $69.3M |
| Q2 2021 | 41 | $66.5M |
| Q1 2021 | 41 | $92.0M |
Institutions, Q3 2022
Shares, value and share of portfolio for each institution holding Elicio Therapeutics, Inc.; share changes are against Q2 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Wells Fargo & Company | 141 | $0 | 0.00% | −43−23.4% | Reduced |
| Royal Bank of Canada | 458 | $0 | 0.00% | +295+181.0% | Added |
| Advisor Group Holdings, Inc. | 2,333 | $2.00K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 2,453 | $2.00K | 0.00% | +1,352+122.8% | Added |
| Barclays PLC | 3,617 | $3.00K | 0.00% | 00.0% | Unchanged |
| Citigroup Inc | 3,743 | $3.00K | 0.00% | −162−4.1% | Reduced |
| Morgan Stanley | 6,404 | $5.00K | 0.00% | −10,852−62.9% | Reduced |
| UBS Group AG | 7,240 | $7.00K | 0.00% | −3,729−34.0% | Reduced |
| State Street Corp | 12,700 | $12.0K | 0.00% | −3,000−19.1% | Reduced |
| HighTower Advisors, LLC | 13,566 | $12.0K | 0.00% | +13,566 | New |
| Man Group plc | 12,614 | $12.0K | 0.00% | +12,614 | New |
| Susquehanna International Group, LLP | 13,661 | $13.0K | 0.00% | −5,675−29.3% | Reduced |
| Qube Research & Technologies Ltd | 14,330 | $13.0K | 0.00% | −1,290−8.3% | Reduced |
| Two Sigma Securities, LLC | 14,592 | $13.0K | 0.00% | +14,592 | New |
| Citadel Advisors LLC | 14,675 | $14.0K | 0.00% | −45,483−75.6% | Reduced |
| CAPROCK Group, Inc. | 15,726 | $14.0K | 0.00% | 00.0% | Unchanged |
| Steward Partners Investment Advisory, LLC | 15,558 | $14.0K | 0.00% | 00.0% | Unchanged |
| BLB&B Advisors, LLC | 22,995 | $21.0K | 0.00% | −33,852−59.5% | Reduced |
| Acadian Asset Management LLC | 24,704 | $22.0K | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 30,282 | $28.0K | 0.00% | −14,222−32.0% | Reduced |
| Northern Trust Corp | 33,788 | $31.0K | 0.00% | +16,732+98.1% | Added |
| Prudential Financial Inc | 34,400 | $32.0K | 0.00% | +17,400+102.4% | Added |
| Patriot Financial Group Insurance Agency, LLC | 36,500 | $34.0K | 0.01% | 00.0% | Unchanged |
| Cannell Capital LLC | 40,181 | $37.0K | 0.01% | +34,072+557.7% | Added |
| BlackRock Inc. | 54,084 | $50.0K | 0.00% | −1,485−2.7% | Reduced |
| Birchview Capital, LP | 54,392 | $50.0K | 0.04% | 00.0% | Unchanged |
| Raymond James & Associates | 60,000 | $55.0K | 0.00% | 00.0% | Unchanged |
| Valeo Financial Advisors, LLC | 63,659 | $59.0K | 0.00% | 00.0% | Unchanged |
| Ergoteles LLC | 78,857 | $73.0K | 0.00% | −10,475−11.7% | Reduced |
| Millennium Management LLC | 125,603 | $116.0K | 0.00% | −57,805−31.5% | Reduced |
| Geode Capital Management, LLC | 168,887 | $155.0K | 0.00% | +81,940+94.2% | Added |
| Bridgeway Capital Management, LLC | 175,000 | $161.0K | 0.00% | +100,000+133.3% | Added |
| Renaissance Technologies LLC | 208,977 | $192.0K | 0.00% | −4,523−2.1% | Reduced |
| Park West Asset Management LLC | 370,724 | $341.0K | 0.03% | +295,221+391.0% | Added |
| CM Management, LLC | 600,000 | $552.0K | 0.62% | +75,000+14.3% | Added |
| Vanguard Group Inc | 643,360 | $592.0K | 0.00% | −127,334−16.5% | Reduced |
| Nantahala Capital Management, LLC | 1,066,012 | $981.0K | 0.10% | −64,989−5.7% | Reduced |
| BVF Inc | 1,071,297 | $986.0K | 0.04% | 00.0% | Unchanged |
| Lake Street Advisors Group, LLC | 0 | $0 | 0.00% | −246,904−100.0% | Sold out |
| Knoll Capital Management, LLC | 0 | $0 | 0.00% | −60,000−100.0% | Sold out |
| Ground Swell Capital, LLC | 0 | $0 | 0.00% | −16,258−100.0% | Sold out |
| Y-Intercept (Hong Kong) Ltd | 0 | $0 | 0.00% | −11,161−100.0% | Sold out |
| FMR LLC | 0 | $0 | 0.00% | −692−100.0% | Sold out |
| New York State Common Retirement Fund | 0 | $0 | 0.00% | −193−100.0% | Sold out |
| Credit Suisse AG | 0 | $0 | 0.00% | −12−100.0% | Sold out |
| Captrust Financial Advisors | 0 | $0 | 0.00% | −300−100.0% | Sold out |